BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|
MBS4381198-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
Ctx Elisa Laboratories manufactures the ctx biomarker elisa reagents distributed by Genprice. The Ctx Biomarker Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ctx elisa. Other Ctx products are available in stock. Specificity: Ctx Category: Biomarker Group: Elisa
Dog True insulin ELISA kit |
|
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Canine True insulin ELISA kit |
|
BlueGene |
48 wells plate |
EUR 280 |
Dog True insulin ELISA kit |
|
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Canine True insulin ELISA kit |
|
BlueGene |
96 wells plate |
EUR 405 |
Bovine True insulin ELISA kit |
|
BlueGene |
48 wells plate |
EUR 280 |
Bovine True insulin ELISA kit |
|
BlueGene |
96 wells plate |
EUR 405 |
Monkey True insulin ELISA kit |
|
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Monkey True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Elisa information
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380253-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380253-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380253-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380254-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380254-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380254-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380254-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
|
MBS4380254-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 1mg/mL |
|
BNUM2430-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL |
|
BNUB2430-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL |
|
BNUB2430-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 1mg/mL |
|
BNUM2759-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 1mg/mL |
|
BNUM2760-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL |
|
BNUB2759-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL |
|
BNUB2759-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL |
|
BNUB2760-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL |
|
BNUB2760-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
